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ABSTRACT
Objectives: The primary objective of this cluster
randomised controlled trial was to compare the
effectiveness of the three experimental continence
promotion interventions against a control intervention
on urinary symptom improvement in older women with
untreated incontinence recruited from community
organisations. A second objective was to determine
whether changes in incontinence-related knowledge
and new uptake of risk-modifying behaviours explain
these improvements.
Setting: 71 community organisations across the UK.
Participants: 259 women aged 60 years and older
with untreated incontinence entered the trial; 88%
completed the 3-month follow-up.
Interventions: The three active interventions
consisted of a single 60 min group workshop on
(1) continence education (20 clusters, 64 women);
(2) evidence-based self-management (17 clusters, 70
women); or (3) combined continence education and
self-management (17 clusters, 61 women). The control
intervention was a single 60 min educational group
workshop on memory loss, polypharmacy and
osteoporosis (17 clusters, 64 women).
Primary and secondary outcome measures: The
primary outcome was self-reported improvement in
incontinence 3 months postintervention at the level of
the individual. The secondary outcome was change in
the International Consultation on Incontinence
Questionnaire (ICIQ) from baseline to 3-month follow-
up. Changes in incontinence-related knowledge and
behaviours were also assessed.
Results: The highest rate of urinary symptom
improvement occurred in the combined intervention
group (66% vs 11% of the control group, prevalence
difference 55%, 95% CI 43% to 67%, intracluster
correlation 0). 30% versus 6% of participants reported
significant improvement respectively (prevalence
difference 23%, 95% CI 10% to 36%, intracluster
correlation 0). The number-needed-to-treat was 2 to
achieve any improvement in incontinence symptoms,
and 5 to attain significant improvement. Compared to
controls, participants in the combined intervention
reported an adjusted mean 2.05 point (95% CI 0.87 to
3.24) greater improvement on the ICIQ from baseline
to 3-month follow-up. Changes in knowledge and self-
reported risk-reduction behaviours paralleled rates of
improvement in all intervention arms.
Conclusions: Continence education combined with
evidence-based self-management improves symptoms of
incontinence among untreated older women. Community
organisations represent an untapped vector for delivering
effective continence promotion interventions.
Trial registration: ClinicalTrials.gov ID number
NCT01239836.
INTRODUCTION
Urinary incontinence is more frequent than
breast cancer, heart disease or diabetes
among older women, but remains a stigma-
tised and untreated condition despite its
high prevalence.1–4 In the USA, Canada, the
UK and other European countries, up to
40% of women aged 65 years and older
experience involuntary urine leakage, but
little more than 15–30% seek care.1–4 Even
fewer physicians feel competent evaluating
or treating incontinence.5 6 Urinary incontin-
ence is associated with obesity, cardiovascular
disease, diabetes, depression, social isolation,
decline in function, falls, nursing home
Strengths and limitations of this study
▪ First study to provide level 1 evidence that con-
tinence promotion is an effective strategy for
improving urinary symptoms among untreated
community-dwelling older women.
▪ Participants were recruited via community orga-
nisations with representation across diverse
socioeconomic strata.
▪ Rates of knowledge acquisition and behaviour
change provide an explanatory mechanism for
the observed improvements in incontinence in
participants receiving the combined education
plus self-management strategy.
▪ Only self-reported outcomes and crude dichot-
omous measures of behaviour change were col-
lected so results must be interpreted with
caution.
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admission and onerous out-of-pocket expenses.6–10 In
many cases incontinence can be improved, and even
cured, when evidence-based diagnostic and treatment
strategies are appropriately applied.6 11–14
It is a commonly held misconception that incontin-
ence is a normal part of ageing.15 Not-for-profit organi-
sations seek to raise continence awareness worldwide
and promote treatment for incontinent individuals.
Media campaigns, brochures and public awareness lec-
tures attempt to destigmatise incontinence and increase
help-seeking, but the effectiveness of these initiatives for
reaching their target population remains unknown.15
Transmission of public health education via community
organisations is an unexplored strategy for improving
urinary symptoms.16 Data from randomised trials are
needed to determine whether the delivery of an
evidence-based continence intervention via community
organisations is an effective method for treating
incontinence.
The primary objective of this cluster randomised con-
trolled trial was to compare the effectiveness of the
three experimental continence promotion interventions
against a control intervention on urinary symptom
improvement in older women with untreated incontin-
ence recruited from community organisations. A second
objective was to determine whether changes in
incontinence-related knowledge, attitudes and new
uptake of risk-modifying behaviours explain improve-
ments in incontinence. We hypothesised that continence
education combined with evidence-based self-
management would yield the greatest improvement in
incontinence symptoms, measured at the level of the
individual, 3 months postintervention.
METHODS
Study design and oversight
A four arm, parallel-group, controlled, cluster rando-
mised trial was conducted. The study design, recruit-
ment methods and interventions have been reported.16
Clustering was at the level of the community organisa-
tion, from whence participants were recruited. The
choice of a cluster design served to prevent contamin-
ation between participants in the same community
organisation. The trial was designed by two of the
authors and was overseen by the full investigator team,
which had full access to the data. The data were col-
lected at community organisations across the UK. All
participants provided written informed consent.
Study population and recruitment
Inclusion criteria for community organisations included
any organisation throughout the UK that consented to
participate in the trial between November 2010 and
September 2012. A community organisation was loosely
defined as any not-for-profit group of individuals with a
shared interest. These included interest and charity
groups, seniors’ housing groups, women’s lobby groups
and Asian caregiver associations.16 Organisations were
contacted strategically by convenience sampling, word of
mouth and referral. A research coordinator approached
community organisations to join the trial by telephone,
email and newspaper advertising.
The inclusion criteria for participants were women
aged 60 years and older who reported urinary incontin-
ence at least once weekly on the International
Consultation on Incontinence Questionnaire (ICIQ),
and who were not under active treatment for incontin-
ence. For privacy reasons, many community organisa-
tions were uncomfortable screening their members for
incontinence in advance, so eligibility to participate in
the trial could only be ascertained by the research
coordinator on the day of delivery of the intervention.16
Eligibility to participate in the trial was established by
asking all attendees at the workshop to complete a base-
line screening questionnaire on arrival. At this time, a
study information sheet and a consent form were distrib-
uted to all participants. All women, regardless of eligibil-
ity or desire to enrol in the trial, were permitted to stay
for the workshop. Only those women who wished to
enrol in the trial submitted the signed consent form to
the workshop facilitator following the delivery of the
intervention, however all attendees were encouraged to
submit the baseline screening questionnaire even if they
were continent or did not wish to participate in the trial.
Interventions
The interventions were applied at the level of each
cluster. The three experimental interventions to be
tested were continence education, self-management
including the distribution of an evidence-based risk
factor reduction tool for incontinence, and a combined
intervention that included both components. The sham
control intervention was a lecture on health promotion
for older women that addressed topics other than incon-
tinence. All interventions were delivered once in group
format to 8–16 women by the same facilitator at a venue
of the organisation’s choosing, and lasted 60–90 min.
A slide presentation with a pre-established script pre-
pared for the facilitator was delivered at each workshop.
The continence promotion intervention incorporated
elements of constructivist learning that challenged older
adults’ erroneous beliefs about accepting incontinence
as a normal part of ageing, and aimed to change atti-
tudes and create new knowledge about the different
types, aetiology, risk factors and treatment options for
urine loss.16 17 The self-management workshop
reviewed the self-management theory in an interactive
format, and provided a customised evidence-based self-
management programme for risk factor modification for
incontinence to each participant.18 19 The programme
targeted pelvic floor muscle weakness, obesity, consump-
tion of caffeinated beverages, smoking, vision loss and
constipation, with instructions on how to keep a bladder
diary to help monitor symptoms. The content of the
combined intervention condensed elements from the
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continence promotion workshop along with the self-
management theory, and provided the customised self-
management tool to participants. The control interven-
tion addressed other non-bladder-related aspects of
older women’s health such as memory problems, poly-
pharmacy, osteoporosis, nutrition, physical fitness and
vision impairment.
Study outcomes
The primary outcome was the participant’s global
impression of improvement in incontinence symptoms,
measured at 3 months postintervention by telephone
interview using the patient’s global impression of
improvement (PGI-I) questionnaire. The PGI-I is a vali-
dated, single-item global rating of change scale that asks
the patient to describe how their incontinence condition
is now compared to how it was prior to the intervention
(very much better, much better, a little bit better, no
change, a little bit worse, much worse and very much
worse).20 The primary outcome, any improvement, was
defined as a rating of a little bit better, much better or
very much better. A secondary outcome, significant
improvement, was defined as much better or very much
better. The ICIQ, which measures the frequency, severity
and bother from incontinence was used at baseline to
screen participants for inclusion to the trial, and was
repeated at follow-up.21 The ICIQ diagnostic item was
used by participants to describe the type of incontinence
at baseline. A pre-8-item and post-8-item questionnaire
on knowledge and attitudes towards incontinence was
administered at baseline and at 3-month follow-up, as
were risk factors and behaviours related to incontin-
ence.17 Risk factors and behaviours included perform-
ance of pelvic floor muscle exercises three times weekly
(yes, no), daily consumption of one cup or more of tea
or coffee (yes, no), fluid intake >1.5 L/day (yes, no),
weight and height (self-report) and smoking status (yes,
no). At 3-month follow-up participants were asked
whether they had sought treatment for urine leakage
during the past 3 months. All follow-up interviews were
performed by the research coordinator, who was blinded
to participant identification.
The original study protocol sought to examine reduc-
tions in urinary frequency as measured on a bladder
diary and reductions in the cost of pad use as primary
and secondary outcomes respectively. However, as soon
as recruitment for the trial started it became apparent
that the distribution of bladder diaries and the objective
measurement of pad use preintervention would not be
possible. This occurred as a result of privacy concerns
expressed by participating community organisations for
revealing and sharing their members’ names and
contact information with the research team prior to the
delivery of the workshops.16 The PGI-I was therefore
used as the revised primary measure of effectiveness
from the onset of the trial. Data on self-efficacy for man-
aging incontinence were also collected, but are not
reported in this article due to problems with
comprehension of the visual analogue response scale
during the 3-month telephone follow-up that occurred
non-differentially among participants in all arms of the
study.
Randomisation and allocation concealment
Group allocation occurred by non-stratified randomisa-
tion in blocked groups of four of consenting organisa-
tions that agreed to host a workshop. An independent
statistician at a distant study site was responsible for ran-
domisation using computer-generated random digits.
Community organisations were informed that one of
four workshops would be delivered on health topics of
interest to older women, but not which one. In this way,
group allocation was concealed from both the clusters
and the individual participants, who were invited by the
host organisation to attend a ‘Women’s Health
Workshop’. The research coordinator remained unaware
of group allocation at the time each community organ-
isation was recruited to the trial because she was only
informed which workshop to prepare for each organisa-
tion several days before each workshop. The trial is con-
sidered open-label because both the research facilitator
who delivered the intervention and the participants who
received it were aware of which intervention was being
delivered.
Sample size
The trial was designed to detect a minimal 35% differ-
ence in the number of participants reporting any
improvement (very much better, much better and a
little bit better on the PGI-I) between the experimental
and control conditions, assuming a rate of improvement
in the control condition as high as 20%, with 80%
power and α 0.05 two sided (n=34). Using an inflation
factor of 1.65 to account for an anticipated maximum
intracluster correlation (ICC) of 0.05 and unequal
cluster size yielded a recruitment target of 56 partici-
pants per group.22
Statistical methods
Differences in baseline characteristics between the four
groups were determined. To assess the primary outcome
we estimated the unadjusted risk difference (prevalence
of the outcome) and 95% CI via generalised estimating
equations (GEEs) for participants who reported any
improvement on the PGI-I. We repeated the same ana-
lysis for those who reported significant improvement.
GEEs with an identity link and an exchangeable correl-
ation structure were used to account for possible correl-
ation between women in the same organisation.23 To
adjust for the imbalance in potential confounders in the
groups at baseline, additional analyses were conducted
using multivariable logistic regression estimated via GEE
with an exchangeable correlation structure. Potential
confounders included age and baseline incontinence
severity (ICIQ score) as continuous predictors, and
living alone, depression, heart disease, falls, arthritis,
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diabetes, high blood pressure, educational status and
general health perception as dichotomous predictors.
Both intent-to-treat (ITT) and per protocol (PP) ana-
lyses were performed. For the ITT analysis, participants
with missing data were assumed to have no change in
incontinence status at 3-month follow-up. The number
needed to treat was calculated as the inverse of the dif-
ference in absolute event rates between the experimen-
tal and control groups.24 We report intracluster
(intracommunity organisation) correlation coefficients
(ICC) from the marginal model using GEE with
assumed exchangeable correlation structure and robust
SEs.25 In cases where an ICC<0 was detected, we
assumed a correlation structure of independence, but
still used the robust variance estimator. The robust vari-
ance estimator is robust to misspecification of the cor-
relation structure, so SEs, CIs and p values are still
correct. To estimate adjusted mean group differences
in ICIQ scores from baseline to 3-month follow-up, we
used GEE with a Gaussian regression model for con-
tinuous outcomes and followed the same procedure
outlined above.
Improvements in incontinence-related knowledge by
intervention type for proportions of individuals respond-
ing correctly to each knowledge questionnaire item at
baseline compared to 3-month follow-up were estimated
using McNemar’s test for matched pair analysis. Rates of
improvement in self-reported risk modifying behaviours
for incontinence were calculated, along with 95% CIs.
Differences in improvement rates between the interven-
tion and the control groups were compared using
Fisher’s exact test using a PP analysis. A difference in
response for each health behaviour item that indicated
adoption of a new risk modifying behaviour was defined
as a positive change at a 3-month follow-up compared to
baseline. Reduced coffee and tea intake refer to indivi-
duals who reduced their consumption to a single cup
per day or less. Weight loss was determined by a positive
response to the question, “Has your weight changed
(yes, no) and if so, how much do you now weigh?” and
evidence of self-reported current weight lower than self-
reported weight at baseline. All statistical analyses were
run using RStudio V.0.97.310.0, an integrated develop-
ment environment for R.
RESULTS
Study participants and follow-up
Four hundred and twenty different community organisa-
tions were approached over an 18-month period to par-
ticipate in the trial. Of these, 17% consented and
succeeded in hosting an intervention, yielding 71 clus-
ters that were randomised. Approximately one-quarter of
the groups contacted refused; 2% expressed interest but
were unable to organise a workshop; and a little over
half failed to give any response although most of them
had been followed up and had received extra informa-
tion on the project.16 figure 1 depicts the study flow of
the clusters and participants through the trial. Seven
hundred and sixty-three women attended the work-
shops, of whom 322 (42%) were known to be eligible
for the trial. The mean number of participants recruited
Figure 1 Flow of participants through the trial.
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from each cluster for the continence promotion group
was 3+2, whereas it was 4+2 for the other three groups.
Eighty per cent (259/322) of known eligible attendees
to the workshops consented to take part in the trial. Two
hundred and twenty-eight of these (88%) were available
for the 3-month follow-up. Table 1 compares the base-
line characteristics of participants in each trial arm.
Primary and secondary outcomes
The highest rate of improvement in incontinence
occurred in the combined intervention group, 66%
compared to 11% in the control group (prevalence dif-
ference 55%, 95% CI 43% to 67%), yielding a
number-needed-to-treat of 2. Thirty per cent of the
combined group reported a significant improvement
compared to 6% of controls (prevalence difference
23%, 95% CI 10% to 36%, number-needed-to-treat of
5). In the adjusted analyses, the likelihood of achieving
a significant improvement in urinary symptoms from
exposure to the combined intervention was five times
greater than exposure to the control intervention (OR
4.94, 95% CI 1.45 to 16.86). Compared to controls, the
participants in the combined intervention reported an
adjusted mean 2.05 point (95% CI 0.87 to 3.24) greater
improvement on the ICIQ from baseline to 3-month
follow-up. The adjusted mean difference in ICIQ scores
was also significantly higher for the continence educa-
tion group compared to the control group (1.33 point
greater improvement (95% CI 0.33 to 2.32)), but not
for the self-management group. The PP analysis for the
primary outcome and the ICC coefficients for each ana-
lysis are shown in table 2.
Table 1 Baseline characteristics and distribution of modifiable risk factors of participants
Continence
education (n=64)
Self-management
(n=70)
Combined
intervention (n=61)
Control
intervention
(n=64)
Mean±SD
Age 70.8±7.9 71.0±6.8 70.4±6.7 74.1±8.1
Mean ICIQ score (±SD)* 8.5±4.4 6.8±3 7.3±5.6 6.7±3.4
% yes
Lives alone 48.4 40.0 37.7 59.4
Education
University degree or
equivalent
31.2 45.7 37.7 19.0
General health perception
Good, very good, excellent 53.1 85.7 80.3 75.0
Fair/poor 45.3 14.3 16.4 25.0
Depression 48.4 35.7 32.8 20.3
Heart disease 35.9 25.7 16.4 21.0
Falls 45.3 31.4 18.0 18.8
Arthritis 78.1 52.9 44.3 57.8
Diabetes 39.1 24.3 18.0 20.3
High blood pressure 59.0 40.0 45.9 55.6
Type of incontinence
Stress only 15.6 12.9 14.8 33.3
Urgency only 32.8 35.7 29.5 20.6
Mixed 45.3 42.9 55.7 39.7
Modifiable risk factors
Performs pelvic floor muscle
exercises three times/week
18.8 15.7 11.9 15.6
Self-reported body mass
index >27 kg/m2†
53.2 53.0 42.4 49.2
Drinks more than 1.5 L of
fluid/day
43.8 44.3 54.1 37.5
Drinks one cup of tea or
more/day
85.9 84.3 73.8 84.4
Drinks one cup of coffee or
more/day
46.9 62.9 65.6 64.1
Smokes 6.3 4.3 4.9 6.2
*ICIQ, International Consultation on Incontinence Questionnaire, used to measure the severity and bother from urinary incontinence. Scores
range from 0 to 21, with higher scores representing worse incontinence.
†Self-reported body mass index: calculated as weight (kg)/height2 (m) based on participant’s self-reported height and weight at baseline.
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Table 2 Prevalence, risk difference and ORs for self-reported improvements in incontinence at 3 months
OR (95% CI)
Prevalence at 3-month follow-up Prevalence difference (95% CI)* Crude Adjusted†
Continence SM Combined Control
Continence
vs control
SM vs
control
Combined
vs control
Continence
vs control
SM vs
control
Combined vs
control
Continence vs
control
SM vs
control
Combined vs
control
Any improvement
Intention-
to-treat
0.59 0.41 0.66 0.11 0.48
(0.33 to 0.64)
0.28
(0.08 to 0.48)
0.55
(0.43 to 0.67)
11.72
(4.54 to 30.21)
5.16
(1.73 to 15.37)
15.51
(6.50 to 37.01)
9.14
(3.05 to 27.37)
2.71
(0.87 to 8.41)
17.63
(5.09 to 61.13)
Per
protocol
0.64 0.47 0.73 0.13 0.51
(0.34 to 0.67)
0.29
(0.07 to 0.51)
0.59
(0.45 to 0.74)
11.45
(4.27 to 30.67)
4.64
(1.48 to 14.56)
17.14
(6.51 to 45.11)
10.40
(3.05 to 35.48)
3.46
(1.08 to 11.03)
23.27
(5.91 to 91.59)
ICC
intention-
to-treat
– – – – 0.02 0.18 0 0.24 0.18 0 0 0.06 0
ICC per
protocol
– – – – 0.03 0.25 0 0.03 0.25 0 0 0.14 0
Very much better or much better
Intention-
to-treat
0.22 0.21 0.30 0.06 0.16
(0.03 to 0.29)
0.14
(0.01 to 0.27)
0.23
(0.10 to 0.36)
4.2
(1.4 to 13.0)
3.8
(1.2 to 12.2)
6.3
(2.2 to 17.7)
2.83
(0.59 to 13.66)
1.81
(0.50 to 6.60)
4.94
(1.45 to 16.86)
Per
protocol
0.24 0.24 0.33 0.08 0.16
(0.02 to 0.30)
0.15
(0.00 to 0.29)
0.26
(0.10 to 0.42)
3.7
(1.2 to 11.3)
3.5
(1.06 to 11.31)
5.8
(2.0 to 17.4)
2.51
(0.48 to 13.18)
2.28
(0.63 to 8.24)
5.32
(1.39 to 20.34)
ICC
intention-
to-treat
– – – – 0.02 0.06 0 0.02 0.06 0 0 0 0
ICC per
protocol
– – – – 0.01 0.08 0.02 0.01 0.08 0 0 0.02 0
*95% CIs were calculated using robust standard errors.
†Adjusted for age, living alone, depression, heart disease, falls, arthritis, diabetes, high blood pressure, educational status, general health perception and baseline incontinence severity score.
ICC, intracluster correlation; SM, self-management.
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Other outcomes
Table 3 shows the changes in incontinence-related
knowledge attributable to the receipt of each interven-
tion. Participants exposed to the combined intervention
showed the greatest acquisition in knowledge, exhibiting
significant within-group improvement on six of eight
questionnaire items. Participants learned that incontin-
ence is not an inevitable or irreversible part of ageing,
that losing weight, changing the type of fluid intake
and performing pelvic floor muscle exercises can
reduce urinary symptoms, and that wearing undergar-
ment protection is not always the best way to manage
incontinence.
The proportion of participants with modifiable risk
factors for incontinence in each group at baseline is
shown in table 1. The adoption of various risk-modifying
behaviours among participants occurred to a different
degree as a result of exposure to all three experimental
but not the control intervention (figure 2). At 3-month
follow-up, the proportion of women reporting uptake of
pelvic floor muscle exercises and weight loss was
significantly higher in the continence education group
(46% and 20%, respectively), the self-management
group (34% and 20%) and the combined intervention
group (53% and 18%) compared to controls (8% and
3%). Many women additionally reduced their coffee
intake and total fluid intake. The proportion of women
who made an appointment to consult a health profes-
sional for urine leakage was 19% in the continence pro-
motion group, 7% in the self-management group, 16%
in the combined intervention group and 4% in the
control group.
DISCUSSION
In this cluster-randomised trial testing the effectiveness
of three different continence promotion interventions,
we found that health education combined with the deliv-
ery of an evidence-based self-management tool via com-
munity organisations to untreated older women yielded
the highest rate of urinary symptom improvement in
66% of recipients, half of whom reported significant
Table 3 Change in incontinence-related knowledge
Continence
education (n=64) Self-management (n=70)
Combined
intervention (n=61) Control (n=64)
1. Urinary incontinence is a normal part of ageing
Baseline % agreement 73.0 79.7 77.0 79.7
3-month follow-up % agreement 36.2 63.9 38.2 82.7
p Value for change* <0.001 0.02 <0.001 0.73
2. Once people start to leak urine, they are never able to control their urine again
Baseline % agreement 41.9 32.9 36.1 50.8
3-month follow-up % agreement 29.3 17.7 7.3 51.9
p Value for change 0.12 0.06 <0.001 1
3. Urine leakage can be caused by many different things
Baseline % agreement 88.9 92.8 88.3 86.9
3-month follow-up % agreement 93.1 88.7 92.7 90.4
p Value for change 1 0.77 0.73 0.63
4. Wearing pads or diapers is the best way to manage urinary incontinence
Baseline % agreement 57.1 40.6 52.5 67.2
3-month follow-up % agreement 36.8 33.9 27.3 69.2
p Value for change 0.03 0.11 0.001 1
5. What you drink can contribute to urine leakage
Baseline % agreement 64.5 66.7 68.3 66.1
3-month follow-up % agreement 77.6 75.8 89.1 68.6
p Value for change 0.26 0.36 0.01 0.77
6. How much you drink can contribute to urine leakage
Baseline % agreement 72.6 65.2 67.2 71.4
3-month follow-up % agreement 77.6 71 76.4 65.4
p Value for change 0.63 0.65 0.36 0.79
7. Losing weight can lead to improvement in incontinence
Baseline % agreement 61.3 74.3 66.1 75
3-month follow-up % agreement 77.6 77.4 90.9 80.8
p Value for change 0.08 0.69 <0.001 0.48
8. Exercising pelvic floor muscles can help control urine leakage
Baseline % agreement 85.5 88.6 85.2 96.9
3-month follow-up % agreement 96.5 96.7 98.2 98.1
p Value for change 0.04 0.13 0.02 1.0
*McNemar’s test for matched-pairs data.
Bold typeface indicate items that showed statistically significant change at p<0.05.
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improvements in incontinence. These outcomes trans-
late into a number-needed-to-treat of 2 and 5, respect-
ively, a magnitude of effect rarely achieved during public
health interventions. Both new knowledge acquisition
and the adoption of risk-modifying behaviours such as
exercise and weight loss occurred as a result of commu-
nity organisations’ involvement in reaching untreated
incontinent women outside the healthcare system.
Strengths and weaknesses of the study
This is the first randomised trial to test the effectiveness
of continence promotion strategies through community
outreach. Both explanatory mechanisms and final
health outcomes were assessed, and the use of a cluster
randomised design was chosen to avoid contamination
of the control group.26 27 Our choice of comparator
controlled for the placebo effect of participating in a
group intervention. Breaches in the fidelity and quality
of implementation of the intervention were minimised
by having the same facilitator deliver each intervention.
Improvements in urinary symptoms were shown with two
validated measures, the PGI-I and the ICIQ. We believe
the results have wide external validity as the community
groups included women with varied educational levels
and wide socioeconomic status.
The results of this study confirm findings from previ-
ous randomised trials suggesting a positive effect of con-
tinence education and self-monitoring strategies on
urinary symptom improvement in untreated incontinent
individuals.28–33 However all previous trials invited parti-
cipants for clinical assessments prior to the delivery of
the intervention, or involved individualised education
sessions. The current trial delivered group continence
interventions without medical or nursing evaluations, in
a true public health approach, to both continent and
incontinent women as part of the regular activities
offered by each community organisation. Rates of
improvement reported in this trial on the PGI-I were
similar to or exceeded those reported in other studies
using self-help booklets, in the range of 50%. Owing to
the nature of recruitment and delivery of the interven-
tion via community organisations, bladder diaries and
pad tests could not be collected preintervention. The
results of our trial can therefore not be directly com-
pared to other trials that used more objective measures
of symptom improvement.
Other limitations also apply. Owing to the nature of
recruiting potential participants, individuals could not
be screened and enrolled in the trial prior to randomisa-
tion of the clusters.27 The result was an imbalance
between groups, accounted for by analyses that took into
account group differences in age, health status and base-
line incontinence severity. The trial was not designed to
measure the dose-response of knowledge acquisition
and behaviour change on urinary symptom improve-
ment. Thus only crude, dichotomous self-reported mea-
sures of behaviour change were collected and should be
interpreted with caution.
Relevance to the discipline
The value of continence promotion interventions likely
reflects the delivery method as well as the quality of the
content. Group interventions that deliver continence
education, self-management information or a combin-
ation of the two will improve incontinence symptoms in
59%, 41% and 66% of recipients, respectively. It is sur-
prising that the self-management intervention alone was
not associated with a significant improvement compared
to sham control in this trial. This can potentially be
explained by the fact that continence education was
completely omitted from the self-management work-
shop, whereas some information on bladder functioning
was provided to participants during the initial work that
tested the self-management tool.19
Implications for practice
Implementation of community-based programmes that
promote behavioural techniques as first-line manage-
ment for incontinence support evidence for the super-
ior efficacy and tolerability of conservative management
Figure 2 Change in risk-modifying behaviours at 3-month follow-up.
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approaches over a pharmacological treatment for incon-
tinence.34 As ‘silent sufferers’ become better informed
that effective strategies exist for improving urinary symp-
toms, patient demand for care will likely increase.
Almost 20% of women made an appointment to discuss
urine leakage with a health professional in the 3 months
following receipt of the continence education interven-
tion. Evidence-based guidelines exist for physicians to
evaluate and manage urinary incontinence when first-
line behavioural strategies fail, and will need to be more
frequently applied.5 11
In conclusion, continence education combined with
self-management delivered via community organisations
to untreated older women with incontinence leads to
symptom improvement in one of every two recipients. At
the current time, the majority of older women with
incontinence do not seek care, and either self-manage
their symptoms inappropriately or use protection to pal-
liate urine leakage.1–4 As incontinence is associated with
multimorbidity and other deleterious health effects,
results from this trial provide strong justification for
public health outreach via community organisations to
reduce urine leakage among untreated individuals.
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